The hypothesis that the overproduction of SAA can cause systemic amyloidosis, i.e., amyloid deposits in various organs that promote thrombosis, together with our findings described above, led us to explore further the possible role of SAA in COVID-19-associated increased adhesion [28,29]. The gene discussed is SAA2; the disease is COVID-19.